Name: UMIN ID:
Unique ID issued by UMIN | UMIN000028909 |
---|---|
Receipt number | R000033040 |
Scientific Title | Evaluating the safety and efficacy of oocyte and embryo vitrification for fertility preservation |
Date of disclosure of the study information | 2017/09/01 |
Last modified on | 2024/03/05 13:24:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/08/30 15:49:11 | ||
2 | Update | 2019/09/02 09:54:30 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Organization Zip code Address Address TEL Address3 Tel3 Organization Organization Address Address Tel |
|
3 | Update | 2019/09/02 09:56:39 | Last follow-up date |
|
4 | Update | 2019/09/03 14:38:49 | Recruitment status Date of IRB |
|
5 | Update | 2020/09/01 09:42:11 | Date of closure to data entry |
|
6 | Update | 2020/09/01 09:43:03 | Publication of results |
|
7 | Update | 2021/03/03 14:16:49 | Other related information Other related information |
|
8 | Update | 2022/03/04 10:34:37 | Other related information Other related information |
|
9 | Update | 2022/09/03 11:02:39 | Last follow-up date Date of closure to data entry Other related information Other related information |
|
10 | Update | 2022/09/03 11:03:37 | ||
11 | Update | 2023/03/05 09:59:01 | Date trial data considered complete Date analysis concluded Other related information Other related information |
|
12 | Update | 2023/09/04 13:24:21 | Classification by specialty |
|
13 | Update | 2023/09/04 13:26:31 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Other related information Other related information |
|
14 | Update | 2023/09/04 13:35:22 | URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures Plan to share IPD Plan to share IPD IPD sharing Plan description IPD sharing Plan description |
|
15 | Update | 2023/09/04 13:35:53 | 1st name of lead principal investigator |
|
16 | Update | 2024/03/05 13:24:53 | Number of participants that the trial has enrolled |